Skip to content
AiONAiON
Medical directoryActive ingredient

Medroxyprogesterone acetate

Synthetic progestogen used in the 2002 WHI study in combination with conjugated equine oestrogens. It is linked to the increased risk of breast cancer seen in that study.

Institutional endorsement by Clínica Evolution

Medical guides

Keep reading

This entry is for information. Your case requires an individual medical assessment.